已核实 DOI PubMed 相关产品: 2

High-level production of l-homoserine using a non-induced, non-auxotrophic Escherichia coli chassis through metabolic engineering

Journal 2021 · IF 9.642 · 发表于 2021 年 2 月 5 日
作者: Yu Zhang,Minhua Wei,Guihong Zhao,Wenjie Zhang,Yingzi Li,Beibei Lin,Yanjun Li,Qingyang Xu,Ning Chen,Chenglin Zhang
阅读全文 在 PubMed 查看

摘要

l -Homoserine is a valuable non-proteinogenic amino acid used in the synthesis of various important compounds. Microbial fermentation has potential value for producing l -homoserine on a large scale, but suffers from a low yield and the need for expensive additives. In this study, a non-induced, non-auxotrophic, plasmid-free Escherichia coli chassis for the high-efficiency production of l -homoserine was constructed. Initially, the l -homoserine degradation pathway was dynamically attenuated. Subsequently, systems metabolic engineering strategies were employed, including reinforcing the synthetic flux, improving NADPH generation, and elevating l -homoserine efflux. The constructed strain HOM-14, produced 60.1 g/L l -homoserine without additional supplements or inducers, which achieved the highest fermentative production efficiency of l -homoserine till date. Moreover, common byproducts, such as acetate, did not accumulate. The strategies presented here can be applied in the further engineering of chassis for the scale-up production of l -homoserine and derivatives.

本研究中使用的阿拉丁产品

2 款产品在本文中被引用